The peptide reconstitution calculator simplifies these calculations
Because GLP-1 drugs are not opioid-based treatments and are not primarily SUD treatments, they are positioned to completely bypass the culture wars surrounding substance use treatment, which will enable them to have a dramatic impact on the global prevalence of addiction, at a scale that existing treatments cannot reach
And if you're asking it, you're likely standing at a crossroads, weighing a major life decision against the sprawling, often confusing world of health insurance
We selected SGLT-2 inhibitors and DPP-4 inhibitors as active comparators, because they are used at a similar disease stage as GLP-1 and are not associated with the outcome
In Italy, treatment recommendations for T2DM vary depending on a patients history of cardiovascular events with or without heart failure as well as tolerability and safety (Table S1)